BDX

VALUE TRAP?

Becton, Dickinson and Company

Healthcare · Rank #174 · Analyzed Jul 13, 2026

$151.94

Current Price

$243.07

Intrinsic Value

+60.0%

Upside/Downside

3.5/10

Score

1.5/5

Quality

Analysis Summary

Valuation Consensus1/2 methods agree

Quality Score1.5/5.0

Framework RatingVALUE TRAP?

Price vs Intrinsic ValueUndervalued by 60.0%

Fair Value Range

Low$98.43

Base (IV)$243.07

High$315.19

Entry Points

Conservative$68.90

Moderate$98.43

Aggressive$170.15

⚠️ Warnings

Cheap (+60%) but low quality (1.5/5) — possible value trap; cheapness may be deserved

Quality & Moat Breakdown

Return on Equity6.7% → 0/1.0

Debt LevelD/E 72 → 0/1.0

Revenue QualityGrowth 7.8%, margin Δ+0.7% +recovery → 1.0/1.0

Moat Strength2.0/5 → 0/1.0

Profit Margins5.1% → 0.5/1.0

Methodology

This analysis uses a unified valuation framework combining three methods, Discounted Cash Flow (3-scenario), Earnings Power Value, and Asset Valuation, with a quality scoring overlay. A stock needs 2/3 valuation methods to agree and a quality score ≥ 3.5/5 for a BUY rating.

Learn how this framework works →

This is a personal analysis tool, not financial advice. Do your own research before making investment decisions.